The decision by pharmaceutical giant AstraZeneca to pause human trials of its coronavirus vaccine should be seen as a positive sign that corners are not being cut, the government and health experts say.
But the Australian Medical Association said the setback also showed the need for the government to broaden its options.
Loading...
Phillip Coorey is the political editor based in Canberra. He is a two-time winner of the Paul Lyneham award for press gallery excellence. Connect with Phillip on Facebook and Twitter. Email Phillip at pcoorey@afr.com
